BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsuzaka T, Shimano H, Yahagi N, Amemiya-kudo M, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Tomita S, Sekiya M, Hasty A, Nakagawa Y, Sone H, Toyoshima H, Ishibashi S, Osuga J, Yamada N. Insulin-Independent Induction of Sterol Regulatory Element-Binding Protein-1c Expression in the Livers of Streptozotocin-Treated Mice. Diabetes 2004;53:560-9. [DOI: 10.2337/diabetes.53.3.560] [Cited by in Crossref: 129] [Cited by in F6Publishing: 121] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Okyere SK, Xie L, Wen J, Ran Y, Ren Z, Deng J, Hu Y. Bacillus toyonensis SAU-19 Ameliorates Hepatic Insulin Resistance in High-Fat Diet/Streptozocin-Induced Diabetic Mice. Nutrients 2021;13:4512. [PMID: 34960064 DOI: 10.3390/nu13124512] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
2 Takeuchi Y, Yahagi N, Aita Y, Mehrazad-Saber Z, Ho MH, Huyan Y, Murayama Y, Shikama A, Masuda Y, Izumida Y, Miyamoto T, Matsuzaka T, Kawakami Y, Shimano H. FoxO-KLF15 pathway switches the flow of macronutrients under the control of insulin. iScience 2021;24:103446. [PMID: 34988390 DOI: 10.1016/j.isci.2021.103446] [Reference Citation Analysis]
3 Afshari A, Salimi F, Nowrouzi A, Khalili MB, Bakhtiyari S, Hassanzadeh G, Shabani M, Ahadi A, Farhadiannezhad M. Differential expression of gluconeogenic enzymes in early- and late-stage diabetes: the effect of Citrullus colocynthis (L.) Schrad. Seed extract on hyperglycemia and hyperlipidemia in Wistar-Albino rats model. Clin Phytosci 2021;7. [DOI: 10.1186/s40816-021-00324-x] [Reference Citation Analysis]
4 Febbraio MA, Karin M. "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis. Cell Metab 2021:S1550-4131(21)00423-X. [PMID: 34619076 DOI: 10.1016/j.cmet.2021.09.004] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Bideyan L, Nagari R, Tontonoz P. Hepatic transcriptional responses to fasting and feeding. Genes Dev 2021;35:635-57. [PMID: 33888557 DOI: 10.1101/gad.348340.121] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Santos-Baez LS, Ginsberg HN. Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. Curr Opin Lipidol 2021;32:200-6. [PMID: 33883445 DOI: 10.1097/MOL.0000000000000756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Aldayel TS, Alshammari GM, Omar UM, Grace MH, Lila MA, Yahya MA. Hypoglycaemic, insulin releasing, and hepatoprotective effect of the aqueous extract of Aloe perryi Baker resin (Socotran Aloe) in streptozotocin-induced diabetic rats. Journal of Taibah University for Science 2020;14:1671-85. [DOI: 10.1080/16583655.2020.1855859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mukherjee V, Ramakrishna P, Bora S, Kotteazeth S. Phytosteroid 28-homobrassinolide targets cholesterol and glucose homeostasis implicating ABCA1 and SREBP role in regulation. Steroids 2021;165:108756. [PMID: 33171131 DOI: 10.1016/j.steroids.2020.108756] [Reference Citation Analysis]
9 Zhou J, Zhe R, Guo X, Chen Y, Zou Y, Zhou L, Wang Z. The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:2307-16. [PMID: 32669864 DOI: 10.2147/DMSO.S251491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Akinnuga AM, Siboto A, Khumalo B, Sibiya NH, Ngubane P, Khathi A. Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model. Can J Gastroenterol Hepatol 2020;2020:2475301. [PMID: 32149046 DOI: 10.1155/2020/2475301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Takanashi M, Kimura T, Li C, Tanaka M, Matsuhashi A, Yoshida H, Noda A, Xu P, Takase S, Okazaki S, Iizuka Y, Kumagai H, Ikeda Y, Gotoda T, Takahashi M, Yagyu H, Ishibashi S, Yamauchi T, Kadowaki T, Liang G, Okazaki H. Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency. Arterioscler Thromb Vasc Biol 2019;39:373-86. [PMID: 30700132 DOI: 10.1161/ATVBAHA.118.311931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mohammed KAA, Ahmed HMS, Sharaf HA, El-Nekeety AA, Abdel-Aziem SH, Mehaya FM, Abdel-Wahhab MA. Encapsulation of cinnamon oil in whey protein counteracts the disturbances in biochemical parameters, gene expression, and histological picture of the liver and pancreas of diabetic rats. Environ Sci Pollut Res Int 2020;27:2829-43. [PMID: 31834580 DOI: 10.1007/s11356-019-07164-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
13 Ramos‐romero S, Hereu M, Atienza L, Amézqueta S, Casas J, Muñoz S, Medina I, Miralles‐pérez B, Romeu M, Torres JL. The Buckwheat Iminosugar d ‐Fagomine Attenuates Sucrose‐Induced Steatosis and Hypertension in Rats. Mol Nutr Food Res 2019;64:1900564. [DOI: 10.1002/mnfr.201900564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Shimizu H, Lu Y, Vella KR, Damilano F, Astapova I, Amano I, Ritter M, Gallop MR, Rosenzweig AN, Cohen RN, Hollenberg AN. Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action. PLoS One 2019;14:e0220717. [PMID: 31404087 DOI: 10.1371/journal.pone.0220717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Zečić A, Dhondt I, Braeckman BP. The nutritional requirements of Caenorhabditis elegans. Genes Nutr 2019;14:15. [PMID: 31080524 DOI: 10.1186/s12263-019-0637-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
16 Hengist A, Koumanov F, Gonzalez JT. Fructose and metabolic health: governed by hepatic glycogen status? J Physiol 2019;597:3573-85. [PMID: 30950506 DOI: 10.1113/JP277767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Sato T, Watanabe Y, Nishimura Y, Inoue M, Morita A, Miura S. Acute fructose intake suppresses fasting-induced hepatic gluconeogenesis through the AKT-FoxO1 pathway. Biochem Biophys Rep 2019;18:100638. [PMID: 31032430 DOI: 10.1016/j.bbrep.2019.100638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Xu L, Li Y, Yin L, Qi Y, Sun H, Sun P, Xu M, Tang Z, Peng J. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3. Theranostics 2018;8:5593-609. [PMID: 30555566 DOI: 10.7150/thno.27425] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 11.5] [Reference Citation Analysis]
19 Xu J, Liu T, Li Y, Yuan C, Ma H, Seeram NP, Liu F, Mu Y, Huang X, Li L. Hypoglycemic and hypolipidemic effects of triterpenoid-enriched Jamun (Eugenia jambolana Lam.) fruit extract in streptozotocin-induced type 1 diabetic mice. Food Funct 2018;9:3330-7. [PMID: 29808185 DOI: 10.1039/c8fo00095f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
20 Kawashima Y, Eguchi Y, Yamazaki T, Karahashi M, Kawai H, Kudo N. Reduction in Secretion of Very Low Density Lipoprotein–Triacylglycerol by a Matrix Metalloproteinase Inhibitor in a Rat Model of Diet-Induced Hypertriglyceridemia. J Pharmacol Exp Ther 2018;366:194-204. [DOI: 10.1124/jpet.117.246165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Farag MR, Alagawany M, Abd El-Hack ME, El-Sayed SAA, Ahmed SYA, Samak DH. Yucca schidigera extract modulates the lead-induced oxidative damage, nephropathy and altered inflammatory response and glucose homeostasis in Japanese quails. Ecotoxicol Environ Saf 2018;156:311-21. [PMID: 29571109 DOI: 10.1016/j.ecoenv.2018.03.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
22 Li J, Yu H, Wang S, Wang W, Chen Q, Ma Y, Zhang Y, Wang T. Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism. Drug Des Devel Ther 2018;12:121-35. [PMID: 29391777 DOI: 10.2147/DDDT.S151860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
23 Hu Y, Semova I, Sun X, Kang H, Chahar S, Hollenberg AN, Masson D, Hirschey MD, Miao J, Biddinger SB. Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways. J Biol Chem 2018;293:2006-14. [PMID: 29222328 DOI: 10.1074/jbc.M117.782557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
24 Zhao G, Wirth D, Schmitz I, Meyer-Hermann M. A mathematical model of the impact of insulin secretion dynamics on selective hepatic insulin resistance. Nat Commun 2017;8:1362. [PMID: 29118381 DOI: 10.1038/s41467-017-01627-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
25 Moslehi A, Nabavizadeh F, Zekri A, Amiri F. Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. Clin Exp Pharmacol Physiol 2017;44:207-12. [PMID: 27813192 DOI: 10.1111/1440-1681.12695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
26 Ter Horst KW, Serlie MJ. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients. 2017;9. [PMID: 28878197 DOI: 10.3390/nu9090981] [Cited by in Crossref: 79] [Cited by in F6Publishing: 114] [Article Influence: 15.8] [Reference Citation Analysis]
27 Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol. 2017;13:710-730. [PMID: 28849786 DOI: 10.1038/nrendo.2017.91] [Cited by in Crossref: 394] [Cited by in F6Publishing: 366] [Article Influence: 78.8] [Reference Citation Analysis]
28 Khalil SR, Awad A, Mohammed HH, Nassan MA. Imidacloprid insecticide exposure induces stress and disrupts glucose homeostasis in male rats. Environ Toxicol Pharmacol. 2017;55:165-174. [PMID: 28850943 DOI: 10.1016/j.etap.2017.08.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
29 Fan Q, Nørgaard RC, Bindesbøll C, Lucas C, Dalen KT, Babaie E, Itkonen HM, Matthews J, Nebb HI, Grønning-Wang LM. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice. Nutrients 2017;9:E678. [PMID: 28661453 DOI: 10.3390/nu9070678] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
30 Matsuo K, Matsusue K, Aibara D, Takiguchi S, Gonzalez FJ, Yamano S. Insulin Represses Fasting-Induced Expression of Hepatic Fat-Specific Protein 27. Biol Pharm Bull 2017;40:888-93. [PMID: 28566630 DOI: 10.1248/bpb.b17-00105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
31 Legeza B, Marcolongo P, Gamberucci A, Varga V, Bánhegyi G, Benedetti A, Odermatt A. Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome. Nutrients 2017;9:E426. [PMID: 28445389 DOI: 10.3390/nu9050426] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
32 Downing LE, Edgar D, Ellison PA, Ricketts M. Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE). Cell Biochem Funct 2017;35:12-32. [DOI: 10.1002/cbf.3247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
33 Bando Y, Ogawa A, Ishikura K, Kanehara H, Hisada A, Notumata K, Okafuji K, Toya D. The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus. Diabetol Int 2017;8:218-27. [PMID: 30603325 DOI: 10.1007/s13340-016-0302-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
34 Zhang S, Zhang H, Wang L, Liu X, Wu Y. Microwave-assisted synthesis of chitosan biguanidine hydrochloride and its regulation on InsR and GLUT2 in insulin resistant HepG2 cells. RSC Adv 2017;7:10108-17. [DOI: 10.1039/c6ra25998g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Xie ZS, Zhong LJ, Wan XM, Li MN, Yang H, Li P, Xu XJ. Petroleum ether sub-fraction of rosemary extract improves hyperlipidemia and insulin resistance by inhibiting SREBPs. Chin J Nat Med 2016;14:746-56. [PMID: 28236404 DOI: 10.1016/S1875-5364(16)30089-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Seyssel K, Meugnier E, Lê KA, Durand C, Disse E, Blond E, Pays L, Nataf S, Brozek J, Vidal H, Tappy L, Laville M. Fructose overfeeding in first-degree relatives of type 2 diabetic patients impacts energy metabolism and mitochondrial functions in skeletal muscle. Mol Nutr Food Res 2016;60:2691-9. [PMID: 27468128 DOI: 10.1002/mnfr.201600407] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Takeuchi Y, Yahagi N, Aita Y, Murayama Y, Sawada Y, Piao X, Toya N, Oya Y, Shikama A, Takarada A, Masuda Y, Nishi M, Kubota M, Izumida Y, Yamamoto T, Sekiya M, Matsuzaka T, Nakagawa Y, Urayama O, Kawakami Y, Iizuka Y, Gotoda T, Itaka K, Kataoka K, Nagai R, Kadowaki T, Yamada N, Lu Y, Jain MK, Shimano H. KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting. Cell Rep 2016;16:2373-86. [PMID: 27545894 DOI: 10.1016/j.celrep.2016.07.069] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
38 Komiya C, Tsuchiya K, Shiba K, Miyachi Y, Furuke S, Shimazu N, Yamaguchi S, Kanno K, Ogawa Y. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PLoS One. 2016;11:e0151511. [PMID: 26977813 DOI: 10.1371/journal.pone.0151511] [Cited by in Crossref: 129] [Cited by in F6Publishing: 139] [Article Influence: 21.5] [Reference Citation Analysis]
39 Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Targher G, Lonardo A. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. Int J Mol Sci. 2016;17:355. [PMID: 27005620 DOI: 10.3390/ijms17030355] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
40 Hozayen WG, Mahmoud AM, Soliman HA, Mostafa SR. Spirulina versicolor improves insulin sensitivity and attenuates hyperglycemia-mediated oxidative stress in fructose-fed rats. J Intercult Ethnopharmacol 2016;5:57-64. [PMID: 27069726 DOI: 10.5455/jice.20151230055930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
41 Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12-22. [PMID: 26727229 DOI: 10.1172/jci77812] [Cited by in Crossref: 540] [Cited by in F6Publishing: 589] [Article Influence: 90.0] [Reference Citation Analysis]
42 Sharawy MH, El-Awady MS, Megahed N, Gameil NM. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver. Can J Physiol Pharmacol 2016;94:488-97. [PMID: 26871756 DOI: 10.1139/cjpp-2015-0385] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
43 Barzegar-fallah A, Alimoradi H, Razmi A, Dehpour AR, Asgari M, Shafiei M. Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology 2015;767:152-9. [DOI: 10.1016/j.ejphar.2015.10.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
44 Sharawy MH, El-Awady MS, Megahed N, Gameil NM. Attenuation of insulin resistance in rats by agmatine: role of SREBP-1c, mTOR and GLUT-2. Naunyn Schmiedebergs Arch Pharmacol 2016;389:45-56. [PMID: 26449613 DOI: 10.1007/s00210-015-1174-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
45 Narasimhan A, Chinnaiyan M, Karundevi B. Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat. European Journal of Pharmacology 2015;761:391-7. [DOI: 10.1016/j.ejphar.2015.04.043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
46 Di Bartolomeo F, Van den Ende W. Fructose and Fructans: Opposite Effects on Health? Plant Foods Hum Nutr 2015;70:227-37. [DOI: 10.1007/s11130-015-0485-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
47 Bindesbøll C, Fan Q, Nørgaard RC, MacPherson L, Ruan HB, Wu J, Pedersen TÅ, Steffensen KR, Yang X, Matthews J, Mandrup S, Nebb HI, Grønning-Wang LM. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J Lipid Res 2015;56:771-85. [PMID: 25724563 DOI: 10.1194/jlr.M049130] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
48 Suzuki T, Muramatsu T, Morioka K, Goda T, Mochizuki K. ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model. Nutrition 2015;31:877-83. [PMID: 25933497 DOI: 10.1016/j.nut.2015.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
49 Huang JB, Zhang Y, Zhou YB, Wan XC, Zhang JS. Effects of epigallocatechin gallate on lipid metabolism and its underlying molecular mechanism in broiler chickens. J Anim Physiol Anim Nutr (Berl) 2015;99:719-27. [PMID: 25521589 DOI: 10.1111/jpn.12276] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
50 Willecke F, Scerbo D, Nagareddy P, Obunike JC, Barrett TJ, Abdillahi ML, Trent CM, Huggins LA, Fisher EA, Drosatos K, Goldberg IJ. Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice. Arterioscler Thromb Vasc Biol 2015;35:102-10. [PMID: 25395613 DOI: 10.1161/ATVBAHA.114.304615] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
51 Bouchard-Mercier A, Rudkowska I, Lemieux S, Couture P, Pérusse L, Vohl MC. SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation. Lipids Health Dis 2014;13:152. [PMID: 25270430 DOI: 10.1186/1476-511X-13-152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
52 Matsuzaka T, Shimano H. Insulin-dependent and -independent regulation of sterol regulatory element-binding protein-1c. J Diabetes Investig 2013;4:411-2. [PMID: 24843688 DOI: 10.1111/jdi.12098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
53 Prakash P, Singh V, Jain M, Rana M, Khanna V, Barthwal MK, Dikshit M. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. European Journal of Pharmacology 2014;727:15-28. [DOI: 10.1016/j.ejphar.2014.01.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
54 Suzuki T, Kumazoe M, Kim Y, Yamashita S, Nakahara K, Tsukamoto S, Sasaki M, Hagihara T, Tsurudome Y, Huang Y, Maeda-Yamamoto M, Shinoda Y, Yamaguchi W, Yamada K, Tachibana H. Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Sci Rep 2013;3:2749. [PMID: 24067358 DOI: 10.1038/srep02749] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
55 Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic Biol Med. 2013;65:952-968. [PMID: 23994574 DOI: 10.1016/j.freeradbiomed.2013.08.174] [Cited by in Crossref: 164] [Cited by in F6Publishing: 145] [Article Influence: 18.2] [Reference Citation Analysis]
56 Liu C, Li Y, Zuo G, Xu W, Gao H, Yang Y, Yamahara J, Wang J, Li Y. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid Based Complement Alternat Med 2013;2013:534084. [PMID: 23737835 DOI: 10.1155/2013/534084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
57 Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A, Deprez P, Lechêne P, Grynberg A, Lairon D, Planells R, Gastaldi M. Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr 2013;52:1865-74. [PMID: 23269653 DOI: 10.1007/s00394-012-0488-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
58 Haas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, Hirschey M, Vaitheesvaran B, Farese RV Jr, Kurland IJ, Graham M, Crooke R, Foufelle F, Biddinger SB. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 2012;15:873-884. [PMID: 22682225 DOI: 10.1016/j.cmet.2012.05.002] [Cited by in Crossref: 136] [Cited by in F6Publishing: 129] [Article Influence: 13.6] [Reference Citation Analysis]
59 Tranchida F, Tchiakpe L, Rakotoniaina Z, Deyris V, Ravion O, Hiol A. Long-term high fructose and saturated fat diet affects plasma fatty acid profile in rats. J Zhejiang Univ Sci B 2012;13:307-17. [PMID: 22467372 DOI: 10.1631/jzus.B1100090] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
60 Fraulob JC, Souza-Mello V, Aguila MB, Mandarim-de-Lacerda CA. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet. Clin Sci (Lond). 2012;123:259-270. [PMID: 22420611 DOI: 10.1042/cs20110373] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
61 Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012;129:557-70. [PMID: 22351884 DOI: 10.1542/peds.2011-2912] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 10.5] [Reference Citation Analysis]
62 Vidal-Alabró A, Gómez-Valadés AG, Méndez-Lucas A, Llorens J, Bartrons R, Bermúdez J, Perales JC. Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase. Int J Endocrinol 2011;2011:707928. [PMID: 22194744 DOI: 10.1155/2011/707928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
63 Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2012;23:203-208. [PMID: 22129639 DOI: 10.1016/j.jnutbio.2011.09.006] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 12.3] [Reference Citation Analysis]
64 Ishizaka N, Hongo M, Sakamoto A, Saito K, Furuta K, Koike K. Liver lipid content is reduced in rat given 7-day administration of angiotensin II. J Renin Angiotensin Aldosterone Syst 2011;12:462-8. [PMID: 21810895 DOI: 10.1177/1470320311415887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
65 Damiano F, Mercuri E, Stanca E, Gnoni GV, Siculella L. Streptozotocin-induced diabetes affects in rat liver citrate carrier gene expression by transcriptional and posttranscriptional mechanisms. Int J Biochem Cell Biol 2011;43:1621-9. [PMID: 21820077 DOI: 10.1016/j.biocel.2011.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
66 Wells JC, Siervo M. Obesity and energy balance: is the tail wagging the dog? Eur J Clin Nutr 2011;65:1173-89. [PMID: 21772313 DOI: 10.1038/ejcn.2011.132] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
67 Okada S, Kobayashi K, Ishikawa M, Inoue N, Yamada N, Shimano H. Abdominal Irradiation Ameliorates Obesity in ob/ob Mice. J Clin Biochem Nutr 2007;40:123-30. [PMID: 18188414 DOI: 10.3164/jcbn.40.123] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
68 Collino M. High dietary fructose intake: Sweet or bitter life? World J Diabetes 2011; 2(6): 77-81 [PMID: 21860690 DOI: 10.4239/wjd.v2.i6.77] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
69 Karasawa T, Takahashi A, Saito R, Sekiya M, Igarashi M, Iwasaki H, Miyahara S, Koyasu S, Nakagawa Y, Ishii K, Matsuzaka T, Kobayashi K, Yahagi N, Takekoshi K, Sone H, Yatoh S, Suzuki H, Yamada N, Shimano H. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2011;31:1788-95. [PMID: 21546605 DOI: 10.1161/ATVBAHA.110.219659] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
70 Leckstrom A, Lew PS, Poritsanos NJ, Mizuno TM. Central melanocortin receptor agonist reduces hepatic lipogenic gene expression in streptozotocin-induced diabetic mice. Life Sciences 2011;88:664-9. [DOI: 10.1016/j.lfs.2011.01.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
71 Rizkalla SW. Health implications of fructose consumption: A review of recent data. Nutr Metab (Lond) 2010;7:82. [PMID: 21050460 DOI: 10.1186/1743-7075-7-82] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 8.6] [Reference Citation Analysis]
72 Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism. 2011;60:805-814. [PMID: 20846698 DOI: 10.1016/j.metabol.2010.07.032] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
73 Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299:E685-E694. [PMID: 20823452 DOI: 10.1152/ajpendo.00283.2010] [Cited by in Crossref: 274] [Cited by in F6Publishing: 244] [Article Influence: 22.8] [Reference Citation Analysis]
74 El Mesallamy HO, El-Demerdash E, Hammad LN, El Magdoub HM. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. Diabetol Metab Syndr 2010;2:46. [PMID: 20591133 DOI: 10.1186/1758-5996-2-46] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
75 Haeusler RA, Han S, Accili D. Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. J Biol Chem 2010;285:26861-8. [PMID: 20573950 DOI: 10.1074/jbc.M110.134023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
76 Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(21): 2579-2588 [PMID: 20518077 DOI: 10.3748/wjg.v16.i21.2579] [Cited by in CrossRef: 115] [Cited by in F6Publishing: 104] [Article Influence: 9.6] [Reference Citation Analysis]
77 Hu XQ, Wang YM, Wang JF, Xue Y, Li ZJ, Nagao K, Yanagita T, Xue CH. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. Lipids Health Dis 2010;9:25. [PMID: 20211032 DOI: 10.1186/1476-511X-9-25] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
78 Gnoni GV, Giudetti AM, Mercuri E, Damiano F, Stanca E, Priore P, Siculella L. Reduced activity and expression of mitochondrial citrate carrier in streptozotocin-induced diabetic rats. Endocrinology 2010;151:1551-9. [PMID: 20203153 DOI: 10.1210/en.2009-1352] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
79 Yamamoto T, Watanabe K, Inoue N, Nakagawa Y, Ishigaki N, Matsuzaka T, Takeuchi Y, Kobayashi K, Yatoh S, Takahashi A. Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin. J Lipid Res. 2010;51:1859-1870. [PMID: 20179320 DOI: 10.1194/jlr.m004234] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
80 Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23-46. [PMID: 20086073 DOI: 10.1152/physrev.00019.2009] [Cited by in Crossref: 700] [Cited by in F6Publishing: 697] [Article Influence: 58.3] [Reference Citation Analysis]
81 Anthonisen EH, Berven L, Holm S, Nygård M, Nebb HI, Grønning-Wang LM. Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem 2010;285:1607-15. [PMID: 19933273 DOI: 10.1074/jbc.M109.082685] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
82 Han C, Wang J, Li L, Zhang Z, Wang L, Pan Z. The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J Exp Biol 2009;212:1553-8. [PMID: 19411549 DOI: 10.1242/jeb.022210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
83 Haas JT, Biddinger SB. Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol 2009;20:206-10. [PMID: 19421055 DOI: 10.1097/MOL.0b013e32832b2024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
84 Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009;89:1760-5. [PMID: 19403641 DOI: 10.3945/ajcn.2008.27336] [Cited by in Crossref: 242] [Cited by in F6Publishing: 234] [Article Influence: 18.6] [Reference Citation Analysis]
85 Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322-1334. [PMID: 19381015 DOI: 10.1172/jci37385] [Cited by in Crossref: 1060] [Cited by in F6Publishing: 1019] [Article Influence: 81.5] [Reference Citation Analysis]
86 Shrestha S, Ehlers SJ, Lee JY, Fernandez ML, Koo SI. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr 2009;139:640-5. [PMID: 19193814 DOI: 10.3945/jn.108.103341] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
87 Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008;88:1733S-7S. [PMID: 19064538 DOI: 10.3945/ajcn.2008.25825D] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 11.5] [Reference Citation Analysis]
88 Poritsanos NJ, Wong D, Vrontakis ME, Mizuno TM. Regulation of hepatic PPARγ2 and lipogenic gene expression by melanocortin. Biochemical and Biophysical Research Communications 2008;376:384-8. [DOI: 10.1016/j.bbrc.2008.08.162] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
89 Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 2008;87:1194-203. [PMID: 18469239 DOI: 10.1093/ajcn/87.5.1194] [Cited by in Crossref: 163] [Cited by in F6Publishing: 149] [Article Influence: 11.6] [Reference Citation Analysis]
90 Kato T, Shimano H, Yamamoto T, Ishikawa M, Kumadaki S, Matsuzaka T, Nakagawa Y, Yahagi N, Nakakuki M, Hasty AH, Takeuchi Y, Kobayashi K, Takahashi A, Yatoh S, Suzuki H, Sone H, Yamada N. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 2008;57:2382-92. [PMID: 18458149 DOI: 10.2337/db06-1806] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
91 Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 2008;7:125-34. [PMID: 18249172 DOI: 10.1016/j.cmet.2007.11.013] [Cited by in Crossref: 322] [Cited by in F6Publishing: 311] [Article Influence: 23.0] [Reference Citation Analysis]
92 Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008;19:16-24. [PMID: 18196982 DOI: 10.1097/MOL.0b013e3282f2b24a] [Cited by in Crossref: 169] [Cited by in F6Publishing: 157] [Article Influence: 12.1] [Reference Citation Analysis]
93 Shimano H, Amemiya-Kudo M, Takahashi A, Kato T, Ishikawa M, Yamada N. Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction. Diabetes Obes Metab. 2007;9 Suppl 2:133-139. [PMID: 17919187 DOI: 10.1111/j.1463-1326.2007.00779.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
94 Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-anderson KS, Farrell GC. Activation of peroxisome proliferator-activated receptor α by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. J Gastroenterol Hepatol 2008;23:267-75. [DOI: 10.1111/j.1440-1746.2007.05157.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
95 Takeuchi Y, Yahagi N, Nakagawa Y, Matsuzaka T, Shimizu R, Sekiya M, Iizuka Y, Ohashi K, Gotoda T, Yamamoto M, Nagai R, Kadowaki T, Yamada N, Osuga J, Shimano H. In vivo promoter analysis on refeeding response of hepatic sterol regulatory element-binding protein-1c expression. Biochemical and Biophysical Research Communications 2007;363:329-35. [DOI: 10.1016/j.bbrc.2007.08.165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
96 Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 2007;13:1193-1202. [PMID: 17906635 DOI: 10.1038/nm1662] [Cited by in Crossref: 354] [Cited by in F6Publishing: 344] [Article Influence: 23.6] [Reference Citation Analysis]
97 de Preux A, Goosen K, Zhang W, Sima AA, Shimano H, Ouwens DM, Diamant M, Hillebrands J, Rozing J, Lemke G, Beckmann JS, Smit AB, Verheijen MH, Chrast R. SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status. Molecular and Cellular Neuroscience 2007;35:525-34. [DOI: 10.1016/j.mcn.2007.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
98 Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, Takahashi A, Yahagi N, Sone H, Suzuki H, Toyoshima H, Yamada N. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 2007;282:11687-95. [PMID: 17296605 DOI: 10.1074/jbc.M611911200] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
99 Shimano H. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling. J Mol Med (Berl). 2007;85:437-444. [PMID: 17279346 DOI: 10.1007/s00109-007-0158-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
100 Im SS, Kwon SK, Kang SY, Kim TH, Kim HI, Hur MW, Kim KS, Ahn YH. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochem J 2006;399:131-9. [PMID: 16787385 DOI: 10.1042/BJ20060696] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
101 Schuster GU, Johansson L, Kietz S, Stulnig TM, Parini P, Gustafsson J. Improved metabolic control by depletion of Liver X Receptors in mice. Biochemical and Biophysical Research Communications 2006;348:176-82. [DOI: 10.1016/j.bbrc.2006.07.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
102 Eller P, Hochegger K, Wehinger A, Tancevski I, Schgoer W, Ritsch A, Patsch JR. Hepatic ENPP1 expression is induced in diabetic rabbits. Mamm Genome 2006;17:886-91. [PMID: 16897338 DOI: 10.1007/s00335-006-0028-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
103 Kato T, Shimano H, Yamamoto T, Yokoo T, Endo Y, Ishikawa M, Matsuzaka T, Nakagawa Y, Kumadaki S, Yahagi N, Takahashi A, Sone H, Suzuki H, Toyoshima H, Hasty AH, Takahashi S, Gomi H, Izumi T, Yamada N. Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice. Cell Metabolism 2006;4:143-54. [DOI: 10.1016/j.cmet.2006.06.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
104 Weickert MO, Pfeiffer AFH. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 2006;49:1732-41. [DOI: 10.1007/s00125-006-0295-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.5] [Reference Citation Analysis]
105 Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem. 2006;281:10105-10117. [PMID: 16492665 DOI: 10.1074/jbc.m600272200] [Cited by in Crossref: 345] [Cited by in F6Publishing: 335] [Article Influence: 21.6] [Reference Citation Analysis]
106 Gabra BH, Berthiaume N, Sirois P, Nantel F, Battistini B. The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biological Chemistry 2006;387. [DOI: 10.1515/bc.2006.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
107 Tao Y, Maegawa H, Ugi S, Ikeda K, Nagai Y, Egawa K, Nakamura T, Tsukada S, Nishio Y, Maeda S, Kashiwagi A. The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes. Endocrinology 2006;147:1685-96. [PMID: 16373417 DOI: 10.1210/en.2005-1304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
108 Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 2006;12:107-13. [DOI: 10.1038/nm1334] [Cited by in Crossref: 132] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
109 Gomez-Valades AG, Vidal-Alabro A, Molas M, Boada J, Bermudez J, Bartrons R, Perales JC. Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi. Mol Ther. 2006;13:401-410. [PMID: 16271515 DOI: 10.1016/j.ymthe.2005.08.026] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
110 Kelley GL, Azhar S. Reversal of high dietary fructose-induced PPARalpha suppression by oral administration of lipoxygenase/cyclooxygenase inhibitors. Nutr Metab (Lond) 2005;2:18. [PMID: 16091142 DOI: 10.1186/1743-7075-2-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
111 Wang H, Kouri G, Wollheim CB. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci. 2005;118:3905-3915. [PMID: 16091421 DOI: 10.1242/jcs.02513] [Cited by in Crossref: 193] [Cited by in F6Publishing: 190] [Article Influence: 11.4] [Reference Citation Analysis]
112 Sandberg MB, Fridriksson J, Madsen L, Rishi V, Vinson C, Holmsen H, Berge RK, Mandrup S. Glucose-induced lipogenesis in pancreatic β-cells is dependent on SREBP-1. Molecular and Cellular Endocrinology 2005;240:94-106. [DOI: 10.1016/j.mce.2005.05.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
113 Amemiya-Kudo M, Oka J, Ide T, Matsuzaka T, Sone H, Yoshikawa T, Yahagi N, Ishibashi S, Osuga J, Yamada N, Murase T, Shimano H. Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. J Biol Chem 2005;280:34577-89. [PMID: 16055439 DOI: 10.1074/jbc.M506718200] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
114 Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-najib J, Holleran S, Cohn JS, Ramakrishnan R, Ginsberg HN. Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 2005;115:1323-32. [DOI: 10.1172/jci200523219] [Cited by in Crossref: 153] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
115 Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R. Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest. 2005;115:1323-1332. [PMID: 15841215 DOI: 10.1172/jci23219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 66] [Article Influence: 0.4] [Reference Citation Analysis]
116 Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005;2:5. [PMID: 15723702 DOI: 10.1186/1743-7075-2-5] [Cited by in Crossref: 453] [Cited by in F6Publishing: 458] [Article Influence: 26.6] [Reference Citation Analysis]
117 Sandberg MB, Bloksgaard M, Duran-sandoval D, Duval C, Staels B, Mandrup S. The Gene Encoding Acyl-CoA-binding Protein Is Subject to Metabolic Regulation by Both Sterol Regulatory Element-binding Protein and Peroxisome Proliferator-activated Receptor α in Hepatocytes. Journal of Biological Chemistry 2005;280:5258-66. [DOI: 10.1074/jbc.m407515200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
118 . Current literature in diabetes. Diabetes Metab Res Rev 2005;21:71-8. [PMID: 15624121 DOI: 10.1002/dmrr.534] [Reference Citation Analysis]
119 Bandsma RHJ, Grefhorst A, van Dijk TH, van der Sluijs FH, Hammer A, Reijngoud D, Kuipers F. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia 2004;47:2022-31. [DOI: 10.1007/s00125-004-1571-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
120 Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004;86:839-48. [DOI: 10.1016/j.biochi.2004.09.018] [Cited by in Crossref: 830] [Cited by in F6Publishing: 851] [Article Influence: 46.1] [Reference Citation Analysis]
121 Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol. 2004;6:351-357. [PMID: 15048126 DOI: 10.1038/ncb1111] [Cited by in Crossref: 243] [Cited by in F6Publishing: 223] [Article Influence: 13.5] [Reference Citation Analysis]